Alnylam stock hits all-time high on amyloidosis drug data
July 11, 2013 at 11:59 AM EDT
Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) stock hit an all-time high Thursday after the biotech announced “robust and statistically significant” effectiveness of its injectable drug candidate for amyloidosis in an early-stage trial...